routin
use
rodent
viru
diagnost
laboratori
yet
approach
level
sophist
gener
achiev
studi
agent
experiment
model
purpos
paper
present
overview
method
commonli
use
isol
identif
virus
infect
laboratori
rodent
case
systemat
comparison
specif
sensit
method
yet
made
howev
conclus
drawn
specif
method
base
upon
report
human
veterinari
diagnost
laboratori
new
techniqu
potenti
applic
rodent
virus
discuss
necess
rapid
diagnost
method
expens
laborintens
natur
viru
detect
method
differenti
diagnosi
consid
laboratori
test
perform
differenti
diagnosi
may
base
clinic
present
frequent
howev
rodent
viru
infect
subclin
diagnost
request
stem
experiment
result
conform
earlier
experi
serologi
test
histologi
examin
thorough
review
husbandri
environment
factor
may
suggest
explan
reason
suspect
infecti
etiolog
sound
differenti
diagnosi
establish
appropri
sampl
may
submit
diagnost
laboratori
consult
diagnost
laboratori
prove
help
investig
point
special
instruct
relat
collect
storag
ship
specimen
may
discuss
exampl
viru
recoveri
method
choic
specimen
collect
asept
maintain
steril
contain
kept
wet
ice
short
period
time
possibl
specimen
collect
acut
phase
diseas
like
yield
posit
result
collect
outbreak
convalesc
diagnost
laboratori
remot
submit
facil
specimen
pack
dri
ice
transport
within
tapes
vial
prevent
exposur
carbon
dioxid
recent
review
method
rapid
diagnosi
human
viru
infect
viru
isol
term
gold
standard
method
compar
viru
isol
result
identif
etiolog
agent
well
preserv
studi
experiment
reproduct
infect
addit
advantag
viru
isol
method
abil
detect
unexpect
assay
use
specif
probe
like
detect
agent
probe
made
wherea
viru
isol
method
may
detect
agent
suspect
circumst
anim
use
mandatori
viru
isol
howev
view
eas
transmiss
mani
rodent
virus
altern
anim
inocul
may
prefer
viru
detect
mani
rodent
virus
prefer
vitro
isol
cell
cultur
suscept
agent
interest
vitro
method
less
expens
anim
inocul
result
often
obtain
quickli
exampl
isol
reoviru
type
transplant
neoplasm
mice
requir
two
week
inocul
newborn
mice
howev
isol
identif
accomplish
within
seven
day
inocul
suscept
mous
l
cell
isol
lymphocyt
choriomening
viru
lcmv
intracrani
inocul
adult
mice
requir
seven
ten
day
wherea
isol
identif
accomplish
hour
use
suscept
cell
cultur
lcmv
usual
induc
detect
cytopath
effect
cpe
identifi
indirect
immunofluoresc
use
refer
immun
reagent
varieti
manipul
may
use
increas
probabl
infect
cultur
cell
one
exampl
use
diethylaminoethyl
deae
dextran
absorpt
medium
enhanc
uptak
viru
cell
use
success
increas
titer
dbt
cell
studi
plaqu
size
increas
inclus
trypsin
overlay
medium
inocul
cell
cultur
identif
infect
viru
critic
step
sinc
mani
rodent
virus
especi
recov
anim
tissu
induc
morpholog
chang
cultur
cell
batteri
reagent
suitabl
use
immunofluores
enzym
immunoassay
essenti
reagent
react
uninfect
mockinfect
cell
method
avail
detect
replic
anim
virus
cell
cultur
includ
detect
hemagglutinin
ha
complementfix
cf
antigen
supern
infect
cultur
former
method
obvious
requir
agent
possess
ha
antigen
latter
method
problemat
stringent
molecular
configur
requir
cf
test
detect
ha
activ
recommend
diagnost
tool
human
adenovirus
canin
parvoviru
infect
latter
case
test
use
chloroformtr
fecal
specimen
report
rapid
specif
hemagglutin
inhibit
hai
test
use
confirm
specif
ha
activ
also
discrimin
cpv
autonom
parvovirus
felin
panleukopenia
viru
mink
enter
viru
minut
viru
canin
hai
test
similarli
discrimin
among
rodent
parvovirus
mous
parvoviru
minut
viru
mice
crawford
strain
parker
et
al
report
induct
cpe
rat
embryo
cell
sensit
method
could
support
detect
ha
cf
antigen
immunofluoresc
immunofluoresc
stain
primari
mous
embryo
cultur
use
detect
antigen
k
viru
induc
cpe
carthew
use
horseradish
peroxidaselabel
antibodi
demonstr
mhv
antigen
cell
expos
less
hour
clinic
materi
natur
infect
mice
experi
mhv
isol
gener
induc
cpe
within
hour
never
detect
antigen
cultur
cpeneg
hemadsorpt
hemadsorpt
inhibit
hadi
test
appli
sendai
viru
howev
test
timeconsum
must
read
microscop
sever
replic
determin
sampl
novel
approach
quantif
infecti
viru
applic
enzym
immunoassay
eia
technolog
monolay
cultur
infect
cell
use
peroxidas
conjug
countabl
foci
herp
simplex
virusinfect
fetal
lung
cell
visual
plume
reaction
product
diffus
supern
assay
equival
sensit
fluoresc
focu
assay
could
interpret
hour
postinfect
well
onset
cytopath
effect
method
also
successfuli
appli
detect
infecti
center
mump
measl
virus
vero
cell
modifi
method
detect
quantif
rodent
virus
cultur
cell
assay
equival
sensit
fluoresc
focu
test
appli
sever
rodent
virus
unpublish
data
specif
readili
demonstr
neutral
infect
techniqu
easili
appli
larg
number
specimen
requir
small
volum
reagent
induc
eye
fatigu
experienc
prolong
view
fluoresc
microscop
cell
cultur
method
viru
isol
readili
appli
rodent
virus
sinc
grow
poorli
continu
cell
line
systemat
survey
commonli
use
cell
line
may
yield
sensit
host
system
agent
trypsin
treatment
known
enhanc
rotaviru
replic
cultur
cell
manipul
includ
use
hyperton
medium
incorpor
cortisol
retino
acid
vitamin
cultur
medium
use
increas
rotaviru
yield
prepar
cell
primari
origin
current
requir
vitro
cultiv
rat
coronavirus
timeconsum
expens
viru
isol
restrict
cell
tissu
tropism
may
also
difficult
recov
exampl
recent
find
strictli
enterotrop
strain
mhv
replic
normal
permiss
nctc
cl
l
cell
line
grow
cell
deriv
murin
rectal
carcinoma
viru
replic
normal
permiss
cell
line
even
passag
cell
antigen
probabl
viru
recoveri
may
reduc
varieti
factor
isol
attempt
made
appear
neutral
antibodi
proport
appar
infecti
viru
decreas
rapidli
addit
virus
produc
mani
noninfecti
particl
often
structur
protein
infecti
virion
theoret
method
detect
viral
compon
could
sensit
detect
infecti
viru
viral
protein
includ
structur
protein
nonstructu
virusspecif
enzym
protein
detect
tissu
section
use
fluorochrom
enzym
immunohistochemistri
method
use
diagnosi
aid
detect
identif
previous
unrecogn
agent
eg
ref
howev
allow
physic
isol
agent
immunofluoresc
stain
frozen
section
long
use
local
viral
antigen
tissu
recent
method
develop
allow
immunochem
stain
tissu
section
process
histolog
examin
human
diagnost
set
method
gener
less
sensit
isol
techniqu
isol
method
sampl
entir
tissu
wherea
antigen
detect
method
usual
sampl
small
section
tissu
hall
ward
recent
report
differenti
preserv
antigen
sendai
viru
mous
lung
tissu
sever
fix
would
seem
wise
compar
sever
procedur
prior
undertak
antigen
detect
studi
clinic
materi
human
diagnost
laboratori
antigen
detect
use
identifi
viral
product
variou
bodi
secret
sensit
immunofluoresc
respiratori
syncyti
viru
nasopharyng
wash
compar
viru
cultur
method
specif
reaction
report
attempt
identifi
rotaviru
antigen
fecal
smear
infect
mice
immunofluoresc
stain
found
interpret
quit
difficult
presum
due
nonspecif
interact
antibodycontain
serum
multipl
antigen
present
fece
among
disadvantag
immunofluoresc
need
fluoresec
microscop
highqual
reagent
autofluoresc
tissu
requir
interpret
experi
determin
endpoint
rel
subject
immunoperoxidas
hand
requir
light
microscop
permit
antigenspecif
stain
background
standard
histologi
stain
endogen
peroxidas
activ
may
interfer
interpret
method
avail
minim
activ
neither
techniqu
potenti
autom
process
larg
number
sampl
one
time
possibl
electron
microscopi
em
may
also
use
detect
virion
viral
antigen
infect
tissu
ultrastructur
studi
expens
timeconsum
unembellish
em
rel
insensit
recent
develop
immunoelectron
microscop
techniqu
identifi
rabi
viru
antigen
site
viru
synthesi
peripher
central
nervou
system
infect
mice
procedur
take
advantag
colloid
goldconjug
staphylococcu
aureu
protein
bind
igg
fraction
immunoglobulin
main
advantag
em
abil
identifi
virusassoci
structur
would
otherwis
morpholog
unidentifi
lowtemperatur
embed
tissu
crucial
preserv
antigen
reactiv
rabi
viru
protein
techniqu
aesthet
pleas
extrem
use
ultrastructur
studi
viral
pathogenesi
recommend
routin
diagnost
procedur
due
cost
time
requir
perform
em
howev
reveal
presenc
viral
mycoplasm
contamin
transplant
tumor
otherwis
unidentifi
laboratori
clearli
sensit
less
expens
timeconsum
method
need
antigen
detect
ria
sensit
perform
rapidli
larg
number
sampl
use
autom
equip
howev
hazard
expens
associ
use
dispos
gammaemit
isotop
suggest
enzymn
immunoassay
may
prefer
altern
c
enzym
immunoassay
eia
eia
offer
advantag
mention
ria
howev
enzym
unstabl
substrat
carcinogen
current
expens
autom
wash
equip
spectrophotomet
may
prohibit
small
laboratori
limit
resourc
nevertheless
sinc
eia
extens
test
human
diagnost
laboratori
discuss
prospect
problem
associ
may
use
sever
variat
eia
avail
literatur
suggest
wide
array
possibl
method
enzym
substrat
antigen
detect
eia
f
involv
adsorpt
antigen
antibodi
captur
solid
phase
usual
well
microtit
plate
plastic
metal
bead
recent
variat
involv
use
nitrocellulos
filter
nonspecif
captur
immobil
antigen
filter
held
within
vacuum
manifold
conform
microtit
format
addit
reagent
wash
may
done
quickli
effici
addit
acidglycin
treatment
may
use
elut
nativ
antibodi
might
otherwis
interfer
detect
antigen
andor
rais
level
background
signal
tradit
solidphas
assay
two
commonli
appli
enzym
eia
horseradish
peroxidas
alkalin
phosphatas
former
plant
product
readili
avail
reason
price
dark
reaction
product
facilit
visual
interpret
howev
peroxidas
lose
activ
contamin
microorgan
antibacteri
agent
methanol
sodium
azid
also
interfer
activ
addit
peroxidas
substrat
carcinogen
avail
fluoresc
substrat
quit
unstabl
contrast
alkalin
phosphatas
stabl
resist
action
bacteriostat
substrat
shown
biohazard
sinc
purifi
anim
sourc
suppli
limit
expens
peroxidas
enzym
less
frequent
use
includ
betagalactosidas
glucos
oxidas
advantag
absent
bodi
fluid
ph
may
gain
applic
clinic
set
virtu
properti
eia
gener
found
less
sensit
isol
detect
human
viru
infect
detect
respiratori
syncyti
viru
eia
compar
sensit
immunofluoresc
howev
cultureposit
specimen
detect
coxsacki
b
virus
cultureposit
sampl
detect
eia
use
eia
thu
limit
necess
perform
isol
eianeg
specimen
sever
manipul
tri
increas
sensit
assay
indirect
method
increas
number
incub
wash
sensit
direct
techniqu
assay
use
abil
clq
bind
antigenantibodi
complex
also
increas
sensit
use
limit
endogen
circul
immun
complex
present
competit
assay
antibodi
either
mix
specimen
unbound
bind
antigen
solid
phase
overcom
problem
howev
antibodi
present
clinic
specimen
caus
fals
posit
reaction
particular
problem
clinic
specimen
serum
cerebrospin
fluid
complementmagnifi
eia
report
sensit
standard
eia
human
rotaviru
detect
unfortun
nonspecif
reaction
also
magnifi
method
sentiment
antigen
detect
eia
reach
limit
potenti
sensit
reason
follow
requir
extens
wash
remov
unbound
reagent
result
dissoci
specif
antigenantibodi
complex
elut
occur
unless
antibodi
use
high
affin
avid
requir
suggest
monoclon
antibodi
limit
valu
eia
sinc
gener
low
affin
use
pool
hybridoma
product
may
help
overcom
difficulti
secondli
interpret
eia
base
rel
strength
specif
nonspecif
background
signal
nonspecif
bind
enzym
solid
phase
clinic
specimen
result
convers
substrat
product
modif
amplifi
specif
signal
gener
increas
background
signal
test
sensit
also
highi
depend
variabl
among
replic
variat
usual
fairli
high
clinic
sampl
purifi
homogen
hand
use
substrat
yield
precipit
product
potenti
distinguish
product
specif
nonspecif
bound
enzym
addit
method
report
detect
singl
herp
simplex
virusinfect
cell
addit
consider
applic
eia
f
least
detect
human
agent
includ
bind
rheumatoidlik
factor
serum
stool
fc
portion
immunoglobulin
access
intern
antigen
frequent
problem
antigenantibodi
complex
clinic
specimen
problem
fc
bind
appar
depend
age
specimen
donor
speci
sourc
refer
immunoglobulin
antigen
access
improv
treatment
specimen
contain
respiratori
syncyti
viru
influenza
viru
nacetylcystein
specimen
contain
adenoviru
sodium
dodecyl
sulfat
treatment
also
denatur
viral
antigen
envelop
virus
present
special
problem
regard
clinic
specimen
often
contain
endogen
antibodi
number
treatment
use
elimin
antibodi
use
high
affin
antibodi
coat
solid
phase
enhanc
success
competit
antigen
elut
antigenantibodi
complex
physic
method
heat
extrem
ph
treatment
denatur
agent
enzym
use
polysaccharid
antigen
care
must
taken
revers
condit
prior
addit
solid
phase
antibodi
also
denatur
treatment
revers
may
accomplish
cool
dialysi
treatment
antiproteolyt
agent
respect
sodium
thiocyan
also
use
dissoci
antigenantibodi
complex
howev
revers
treatment
result
reaggreg
complex
method
ultracentrifug
gel
exclus
chromatographi
effect
ineffici
human
situat
requir
rapid
diagnosi
treatment
mild
reduc
agent
cysteinehcl
glutathion
effect
antigen
denatur
igg
igm
remov
dialysi
clearli
better
method
dissoci
immun
complex
clinic
specimen
need
detect
antigen
calf
fece
eia
found
sensit
em
immunofluoresc
cf
immunoelectrophoresi
addit
eia
simpl
perform
suitabl
process
larg
batch
clinic
specimen
commerci
eia
test
abil
detect
rotaviru
antigen
specimen
pig
hors
cattl
dog
sheep
exot
rumin
gave
accur
result
within
hour
receipt
specimen
anoth
studi
human
rotaviru
diagnosi
eia
compar
em
solid
phase
aggreg
coupl
erythrocyt
space
assay
similar
concept
eia
except
antibodyco
erythrocyt
replac
enzymesubstr
reaction
indic
space
less
sensit
eia
eia
equival
sensit
em
rotaviru
detect
howev
eia
quicker
less
laborintens
less
expens
em
treatment
rotaviru
antigen
chaotrop
agent
nascn
guanidinehcl
report
increas
sensit
eia
threeto
fivefold
due
enhanc
immobil
antigen
solid
phase
area
eia
methodolog
receiv
adequ
attent
direct
measur
viral
enzym
approach
requir
absenc
enzym
host
cell
fluid
abil
distinguish
enzym
viral
host
origin
neuraminidas
influenza
parainfluenza
virus
detect
eia
use
fluoresc
substrat
bacteria
also
contain
associ
nueraminidas
presenc
clinic
specimen
hinder
interpret
assay
result
thymidin
kinas
herp
simplex
virus
differenti
activ
variou
substrat
compar
kinas
mammalian
origin
assay
base
direct
detect
enzym
detect
two
virusinfect
cell
one
sampl
detect
dna
polymeras
hepat
b
viru
associ
fals
posit
reaction
due
presenc
mammalian
bacteri
polymeras
similar
reactiv
assay
detect
rnadepend
rna
polymeras
evalu
promis
sinc
host
cell
incap
synthes
rna
directli
rna
templat
use
polyllysin
bind
antigen
solid
phase
pool
immun
serum
marker
eia
develop
detect
broad
spectrum
human
enter
virus
includ
coxsacki
echoviru
polio
type
reoviru
type
assay
detect
two
porcin
enterovirus
rapid
inexpens
although
less
sensit
viru
isol
eia
thought
potenti
detect
import
noncultivat
human
enter
pathogen
eg
norwalk
agent
hepat
howev
stool
specimen
present
special
problem
develop
eia
f
contain
multipl
extran
antigen
nucleic
acid
hybrid
appli
diagnost
set
number
human
virus
includ
epsteinbarr
viru
hepat
b
viru
herp
simplex
viru
hsv
human
rotavirus
adenoviru
cytomegaloviru
genom
probe
high
low
specif
produc
former
detect
specif
viru
wherea
latter
may
detect
viru
complex
complementari
nucleic
acid
strain
bind
high
avid
hybrid
assay
quit
sensit
four
hsvinfect
cell
infecti
unit
viru
may
detect
method
hybrid
assay
drawback
sensit
present
roughli
equival
eia
requir
sophist
equip
isotop
expens
difficult
dispos
one
solut
convers
isotop
probe
use
biotinyl
one
detect
colorimetr
probe
may
use
nucleic
acid
immobil
filter
tissu
situ
long
shelf
life
least
one
year
result
low
level
nonspecif
bind
use
reduc
problem
isotop
dispos
time
formerli
requir
develop
autoradiograph
studi
compar
hybrid
cultur
detect
influenza
viru
infect
nonhuman
primat
viral
rna
detect
sever
day
anim
becam
cultureneg
suggest
hybrid
worthi
develop
diagnost
tool
result
consist
concept
product
neutral
antibodi
interfer
abil
detect
infecti
viru
man
hybrid
find
must
interpret
caution
studi
chronic
neurolog
syndrom
multipl
sclerosi
amyotroph
later
sclerosi
postpoliomyel
weak
hybrid
situ
demonstr
materi
control
patient
waksman
reynold
term
find
molecular
archeolog
emphas
difficulti
present
diagnost
set
detect
viral
genom
agent
patient
expos
year
prior
onset
chronic
hybrid
yet
appli
rodent
virus
clinic
set
although
hybrid
frozen
whole
bodi
section
suckl
mice
report
polyoma
viru
use
biotinyl
probe
studi
viral
pathogenesi
also
appli
nucleic
acid
detect
procedur
doublestrand
rna
viru
edim
gene
doublestrand
ds
rna
virus
separ
basi
molecular
weight
polyacrylamid
gel
glyoxal
agaros
gel
electrophoresi
ds
rna
one
techniqu
serv
basi
rel
new
disciplin
molecular
epidemiolog
use
method
murin
rotaviru
detect
lie
fact
edim
grow
poorli
cell
cultur
far
test
laboratori
detect
directli
fecal
materi
extract
label
end
rna
molecul
electrophores
sever
sampl
process
simultan
allow
differenti
isol
comparison
rna
migrat
pattern
serologi
test
pair
acut
convalesc
serum
sampl
diagnost
rise
antibodi
titer
first
second
blood
collect
tradit
use
studi
viral
epidemiolog
approach
sure
tax
resourc
larg
decentr
laboratori
anim
facil
howev
immun
respons
use
extens
criterion
detect
rodent
viru
infect
detect
anamnest
antibodi
respons
challeng
call
method
choic
diagnosi
mhv
ectromelia
viru
infect
routin
diagnost
procedur
techniqu
seem
pose
unnecessari
risk
anim
facil
one
applic
immun
respons
diagnosi
rodent
viru
infect
antibodi
product
test
renew
interest
test
diagnositc
method
test
greatli
enhanc
sensit
avail
monoclon
antibodi
genet
engin
product
produc
eventu
clinic
trial
human
mani
reagent
made
rodent
rodent
cell
must
test
contamin
infecti
agent
includ
convent
rodent
virus
distinct
advantag
antibodi
product
test
direct
isol
procedur
fact
anim
produc
antibodi
live
inactiv
viru
howev
immun
respons
inactiv
viru
protein
subunit
usual
inferior
follow
inocul
whole
replic
viru
therefor
use
procedur
detect
nonrepl
viru
viral
subunit
examin
care
caution
must
exercis
interpret
antibodi
product
test
result
reliabl
test
perform
parker
et
al
report
mous
antibodi
product
map
test
sensit
jui
vitro
induct
cpe
identif
field
strain
mvm
howev
jln
vitro
detect
method
immunofluoresc
stain
inocul
cell
compar
row
cowork
compar
develop
hai
antibodi
map
test
cpe
induct
test
primari
mous
embryo
cultur
tumor
product
suckl
hamster
titrat
detect
polyoma
viru
tissu
cultur
map
test
compar
sensit
reproduc
time
requir
complet
limit
dilut
cpe
appar
day
hai
antibodi
usual
present
day
determin
tumor
product
problemat
due
difficulti
reproduc
antibodi
product
test
systemat
compar
newer
method
viru
detect
view
potenti
human
applic
rodent
product
sensit
antibodi
product
test
rel
eia
f
immunofluoresc
method
compar
order
determin
reliabl
safeti
test
rapid
diagnosi
import
human
viru
diagnost
laboratori
number
compel
reason
chief
among
fact
antivir
drug
significantli
allevi
cours
viru
infect
sinc
singl
syndrom
may
caus
sever
differ
agent
one
may
respond
certain
antivir
import
distinguish
among
possibl
etiolog
particularli
import
drug
toxic
sideeffect
extrem
expens
rapid
diagnosi
may
also
contribut
prompt
initi
epidemiolog
control
measur
vaccin
campaign
although
patient
manag
probabl
never
norm
rodent
coloni
prevent
control
utmost
import
especi
zoonot
agent
lymphocyt
chorioraening
viru
hantaan
relat
virus
addit
sever
contributor
symposium
emphas
impact
intercurr
infect
sever
rodent
virus
basic
research
thu
zoonot
potenti
impact
infect
research
object
consid
decis
regard
need
rapid
method
sever
method
exist
studi
movement
virus
within
among
rodent
coloni
distinguish
vaccin
virusinduc
infect
wild
type
infect
perhap
frequent
use
method
differenti
virus
epidemiolog
studi
neutral
test
nt
kinet
time
nt
variat
allow
discrimin
among
close
relat
virus
distinguish
tradit
nt
assay
degre
neutral
frequent
earli
interv
mixtur
antibodi
viru
rate
neutral
calcul
prior
reaction
equilibrium
one
issu
address
form
antibodi
use
success
detect
differ
among
viru
strain
hyperimmun
sera
ascit
fluid
often
use
titer
reagent
significantli
higher
singleshot
immun
sera
howev
hyperimmun
result
induct
broadli
crossreact
antibodi
less
like
discrimin
among
close
relat
viru
strain
exampl
child
et
al
recent
publish
result
crossneutr
antibodi
assay
use
six
refer
strain
mous
hepat
viru
mhv
hyperimmun
ascit
fluid
prepar
five
strain
data
suggest
strain
close
relat
indistinguish
conclud
kinet
neutral
test
determin
antigen
relationship
murin
coronavirus
contrast
found
refer
mhv
strain
easili
distinguish
one
anoth
tradit
nt
provid
singleshot
immun
sera
use
sourc
antibodi
abil
ectromelia
viru
agglutin
mous
erythrocyt
report
reliabl
method
differenti
infect
agent
infect
vaccin
poxvirus
oligonucleotid
fingerprint
appli
epidemiolog
tool
studi
mhv
theiler
murin
encephalomyel
viru
tmev
basic
method
involv
digest
label
virion
rna
tl
rnase
specif
cleav
guanosin
residu
polynucleotid
twelv
greater
base
residu
resolv
base
composit
chain
length
two
dimension
electrophoresi
polyacrylamid
care
must
exercis
interpret
result
howev
sinc
method
detect
viral
genom
thu
differ
fingerprint
may
constru
indic
differ
genom
ident
fingerprint
mean
portion
genom
measur
ident
rapid
evolut
rna
virus
polio
viru
epidem
chief
limit
techniqu
sinc
distant
relationship
may
go
undetect
recent
advanc
report
tmev
analysi
rna
extract
directli
anim
tissu
elimin
need
grow
viru
cultur
cell
step
could
increas
risk
select
variant
viru
popul
restrict
enzym
use
map
genom
dnacontain
virus
defin
differ
close
relat
strain
singl
viru
method
gain
routin
clinic
applic
base
abil
distinguish
hsv
type
endonucleas
digest
one
earliest
molecular
method
use
compar
prototyp
immunosuppress
strain
mvm
genet
conserv
also
studi
nucleic
acid
hybrid
use
electrophoret
separ
segment
doublestrand
rna
virus
possibl
determin
segment
gene
extent
genet
method
appli
sever
genera
within
reoviru
famili
review
may
futur
contribut
understand
epizootiolog
rodent
monoclon
antibodi
power
tool
discrimin
virus
andor
strain
indistinguish
method
exampl
virolog
dogma
antigen
variat
among
laboratori
strain
field
isol
rabi
viru
identif
sever
african
virus
distinct
relat
rabi
viru
dogma
question
bit
decad
later
applic
hybridoma
technolog
question
suggest
minor
differ
antigen
structur
rabi
viru
strain
monoclon
antibodi
also
potenti
distinguish
wild
type
vaccin
virusinduc
infect
approach
recent
report
distinct
poliomyel
result
wild
type
viru
vs
sabin
vaccin
applic
monoclon
antibodi
diagnost
problem
may
limit
extraordinari
specif
use
pool
hybridoma
product
may
overcom
limit
learn
biolog
epizootiolog
rodent
viru
infect
may
find
method
discuss
must
appli
standard
monitor
safeti
test
vaccin
inevit
develop
discuss
vaccin
control
agent
rodent
virus
alreadi
begun
human
virolog
teach
us
howev
must
approach
issu
control
caution
must
first
adopt
standard
use
laboratori
preliminari
effort
made
direct
need
done
exercis
recent
publish
polio
neutral
antibodi
test
serv
excel
exampl
sera
distribut
test
laboratori
twelv
countri
analysi
result
reveal
greater
tenfold
variat
sensit
test
use
base
result
protocol
propos
larg
scale
determin
polio
viru
antibodi
also
suggest
antibodi
titer
express
intern
unit
rel
refer
standard
obviat
inevit
problem
laboratori
variat
similar
standard
guidelin
adopt
laboratori
perform
rabi
viru
diagnosi
prior
institut
control
measur
andor
vaccin
infecti
agent
human
anim
situat
sever
biolog
characterist
must
consid
multipl
strain
agent
afford
signific
crossprotect
long
infect
host
capabl
transmit
infect
susceptibi
contact
mani
potenti
rout
transmiss
exist
question
particularli
relev
laboratori
anim
situat
would
vaccin
result
type
interfer
eg
immunosuppress
induc
wild
type
infect
field
diagnost
virolog
current
state
transit
statement
particularli
true
laboratori
anim
facil
frequent
extrapol
technolog
advanc
human
diagnost
laboratori
howev
must
keep
mind
differ
popul
interest
impact
diseas
popul
consider
doubt
modifi
object
cours
action
view
rel
immobl
access
popul
interest
may
find
longterm
goal
develop
program
emphas
erad
facil
modern
rather
support
develop
diagnost
technolog
vaccin
